PRMT3 and neoplasm: In this study, we identified the tumor-intrinsic PRMT, PRMT3, as a significant player in the resistance to radiotherapy of NSCLC, regulating Kyn metabolism via the TFAP2A–IDO1 axis within tumor cells.